Investigational peptide studied for selectively disrupting the blood supply to white adipose (fat) tissue, causing fat cells to shrink through localized apoptosis rather than acting on appetite or metabolism directly; not FDA-approved, and studies documented reversible kidney toxicity findings that have significantly limited further human development.
Investigational peptide studied for selectively disrupting the blood supply to white adipose (fat) tissue, causing fat cells to shrink through localized apoptosis rather than acting on appetite or metabolism directly; not FDA-approved, and studies documented reversible kidney toxicity findings that have significantly limited further human development.
| Concentration | 1 mg/mL |
|---|---|
| Volume | 5 mL |
| Total mg/Vial | 5 mg |
